All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 8, 2023
Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
Conferences, BioWorld Science RSS Feed RSS

Illustration of cancer cells and immunotherapy treatment
Immuno-oncology

Carisma Therapeutics reports preclinical development of a novel mesothelin-targeting CAR-M for solid tumor immunotherapy

Nov. 18, 2022
No Comments
Researchers from Carisma Therapeutics Inc. have provided details on the discovery and preclinical evaluation of a novel mesothelin-targeting chimeric antigen receptor macrophage (CAR-M), CT-1119, being developed as a potential solid tumor immunotherapy candidate.
Read More
Immuno-oncology

KZR-540 blocks PD-1 expression and inhibits tumor growth in vivo

Nov. 18, 2022
No Comments
Preclinical studies have found that targeting...
Read More
Cancer

Kinensus designs and tests AXL/MER inhibitors

Nov. 18, 2022
No Comments
The TAM family of receptor tyrosine kinases...
Read More
Immuno-oncology

Encouraging preclinical results reported for ASKG-915, a new cytokine prodrug fusion protein

Nov. 18, 2022
No Comments
Researchers from Askgene Pharma Inc...
Read More
Liver disease
Gastrointestinal

ID-119031166 improves NASH and liver fibrosis in hamsters

Nov. 18, 2022
No Comments
ID-119031166 is a non-bile acid farnesoid X...
Read More
Neurons
Neurology/Psychiatric

Intra-DRG administration of RLVT-14-02 effective against neuropathic pain in preclinical model

Nov. 18, 2022
No Comments
Neuropathic pain (NP) is caused by damage or...
Read More
Brain and encephalography
Neurology/Psychiatric

CACNB3 as novel therapeutic target in mesial temporal lobe epilepsy

Nov. 17, 2022
No Comments
Investigators at the University of Copenhagen and affiliated organizations presented data from a study that aimed to validate differentially expressed genes (DEGs) in mesial temporal lobe epilepsy (mTLE) as potential new targets.
Read More
Cancer cells being destroyed by immunotherapy
Immuno-oncology

Anti-EPN1 antibody enhances the efficacy of anti-PD-L1 therapy in model of melanoma

Nov. 17, 2022
No Comments
Epsin 1 (EPN1) is an adapter protein involved in clathrin-mediated endocytosis and upregulated in multiple cancers.
Read More
Neurology/Psychiatric

Mindset Pharma presents preclinical data on MSP-1014

Nov. 17, 2022
No Comments
Psilocybin is a prodrug of psilocin, which is thought to mediate antidepressant effects...
Read More
Central nervous system
Neurology/Psychiatric

RTI-122 as a potent GPR88 agonist for CNS-related disorders

Nov. 17, 2022
No Comments
RTI International has presented results on RTI-122, a G protein-coupled receptor 88...
Read More
Previous 1 2 … 7 8 9 10 11 12 13 14 15 … 2868 2869 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld
    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 8, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Feb. 8, 2022.
  • Setpoint Medical - vagus nerve stimulation device

    Setpoint Medical lands up to $145M to advance RA implant

    BioWorld MedTech
    Bioelectronic medicine startup Setpoint Medical Corp. raised $80 million in a preferred stock financing co-led by new investors Norwest Venture Partners and...
  • Brain with clock hands, day and night background

    12-Hour as well as circadian brain rhythms disrupted in people with schizophrenia

    BioWorld Science
    Research shows that individuals with schizophrenia have abnormal gene expression patterns in their brains compared with people without the condition. In a study...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing